Press Releases

DUBLIN and NEW YORK, Dec. 23, 2019 /PRNewswire/ -- Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Pfizer Inc. (NYSE: PFE) ("Pfizer") today announced that the companies have entered into a global license agreement for Theravance Biopharma's preclinical progr

WOODCLIFF LAKE, N.J., Dec. 23, 2019 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and 10 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

MEMPHIS, Tenn., Dec. 23, 2019 /PRNewswire/ -- Gaming professional DrLupo raised more than $2.3 million in his second annual 24-hour livestream today to support

OKLAHOMA CITY, Dec. 23, 2019 /PRNewswire/ -- Dracula and The Nutcracker might not be the first things that come to mind when you think about professional sport injuries, but studies show these performances are tough on dancers.

MIAMI, Dec. 23, 2019 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of end-of-life care, has named Dr. Shirley Codada, an internal medicine physician who specializes in hospice and palliative care, as regional medical director for its programs serving Northern Florida and

SYOSSET, N.Y., Dec. 23, 2019 /PRNewswire/ -- Micro Merchant Systems has announced its industry leading PrimeRx™ pharmacy management operating system now offers direct integration with Script Management Partners (SMP) for automated immunization registry reporting.  This critical function is available on a subscription basis and allows pharmacies to seamles

Valens announces four-year extraction and white label agreement with Emerald Health Therapeutics Inc. with annual minimum quantities of 10,000 kilograms Valens enters into multi-year distillate and SōRSE emulsion supply agreement with large-scale confectionary company, Dynaleo Inc. Valens agreements containing white label services officially surpass nu

NYSE | TSX: ACBInitial cannabis 2.0 shipments released to 10 provincial regulators; new products have also been made available for order countrywide by Aurora's registered medical patients Provides Update on Capital Expenditure Plan Aligned to Long-Term Market Growth Network of Strategic Partners Continue to Demonstrate Value and Strong Execution

NEW YORK, Dec. 23, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological and immunological disorders such as atopic dermatitis, psoriasis, asthma and acne, today issued its 2019 Shareholder Letter.Dear Shareholder,  Looking bac

TEL AVIV, Israel, Dec. 23, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology to enable the functional selection of stem cells, has received approval to initiate the trial in the U.S. to evaluate the safety and tolerability of the ApoGraft technology for haploidentical bone marrow transplantations. The company is col